Jupiter Diagnostics previously known as L3T is addressing the $10bn global market for cholesterol testing, using technology from a leading team of scientists based at STFC’s Daresbury Laboratory in Cheshire to develop a diagnostic tool for full spectrum cholesterol testing at the point of care.
A 2004 RSF pathfinder funded some confirmatory research to back up claims in a patent, with further investment since taking the total to £242,000. The company has recently raised a further £1.7m from angels and venture funds and expects to have a fully functioning device within the next six to twelve months.
